Skip to main content
SpringerLink
Log in

Perspective: Second-Class Medicine – Implications of Evidence-Based Medicine for Improving Minority Access to Health Care

  • Chapter
  • First Online:
Healthcare Disparities at the Crossroads with Healthcare Reform

Abstract

The Promise of Evidence-Based Medicine. The spectacular ascent of medical science at the dawn of the twenty-first century trumpets a new era in US health care and great possibilities for preserving human health. At the same time, it poses serious challenges for policymakers who must make crucial decisions about the safety, efficacy, and affordability of medical technologies. One of the most difficult and contentious matters confronting decision-makers is the question of how to ensure the delivery of lifesaving technologies to low-income and minority patient populations, whereas simultaneously controlling ever-rising health-care costs. In theory, the increasingly popular concept of evidence-based medicine (EBM) suggests a potential tool for both cost containment and the reduction of severe racial and ethnic disparities in health-care delivery. Drawn from systematic reviews of studies that use rigorous research methods, particularly the randomized controlled trial, the “evidence” guiding EBM protocols informs treatment decisions made by physicians, as well as policy decisions regarding the allocation of health technologies at the population level. Operating largely out of the “average” American’s view, EBM protocols are policy devices that set the rules for who gets what medical care and on what terms. The foremost claim of some advocates of EBM is that it serves this function well by providing the best available “evidence” about therapeutic interventions, thereby enhancing the capacity of policymakers and physicians to make sound, defensible decisions. At least in theory, the use of EBM should lead invariably to rational decisions so that patients with the same illnesses and clinical indications receive appropriate interventions regardless of race or ethnicity. Again in theory, policy decisions made within EBM frameworks should lead to evenhandedness in the allocation of therapeutic interventions at the population level. Thus, EBM offers the “implicit promise of greater fairness than previously existed” (Poolsup et al., J Clin Pharm Ther 25:197–220, 2000; Taylor et al., N Engl J Med 351:2049–2057, 2004; Yancy, J Card Fail 6:183–186, 2000; Rogers, J Med Ethics 30(2):141–145, 2004).

R.W. Maxey

Past President, National Medical Association, President and Ceo, Executive Healthwatch, Inc., Los Angeles, California, USA

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Taylor SE, Braithwaite RL. African American health: an overview. In: Braithwaite RL, Taylor SE, editors. Health issues in the Black community. 2nd ed. San Francisco, CA: Jossey-Bass, Inc.; 2001. p. 371.

    Google Scholar 

  2. DuBois WEB. The Philadelphia Negro: a social study. Philadelphia, PA: University of Pennsylvania Press; 1998.

    Google Scholar 

  3. Byrd WM, Clayton LA. An American health dilemma: a medical history of African Americans and the problem of race: beginnings to 1900, vol. 1. 1st ed. New York: Routledge; 2000.

    Google Scholar 

  4. Byrd WM, Clayton LA. An American health dilemma: race, medicine, health care in the United States 1900–2000, vol. 2. 1st ed. New York: Brunner-Routledge; 2002.

    Google Scholar 

  5. Smedley BD, Stith AY, Nelson, AR. Unequal treatment: confronting racial and ethnic disparities in health care. Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Washington, DC: Institute of Medicine National Academies Press; 2003.

    Google Scholar 

  6. The Sullivan Commission on Diversity in the Healthcare Workforce. Missing persons: minorities in the health professions. Washington, DC: National Academies Press; 2004.

    Google Scholar 

  7. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in medicare managed care. N Engl J Med. 2005;353(7):692–700.

    Article  PubMed  CAS  Google Scholar 

  8. Vaccarino V, Rathore SS, Wenger NK, et al. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353(7):671–82.

    Article  PubMed  CAS  Google Scholar 

  9. Jha AK, Fisher ES, Li Z, Orav EJ, Epstein AM. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005;353(7):683–91.

    Article  PubMed  CAS  Google Scholar 

  10. Steinberg EP, Luce BR. Evidence based? Caveat emptor! Health Aff. 2005;24(1):80–92.

    Article  Google Scholar 

  11. Gelijins AC, Brown LD, Magnell C, Ronchi E, Moskowitz AJ. Evidence, politics, and technological change. Health Aff. 2005;24(1):29–40.

    Article  Google Scholar 

  12. Helfand M. Using evidence reports: progress and challenges in evidence-based decision making. Health Aff. 2005;24(1):123–7.

    Article  Google Scholar 

  13. Humphreys K, Weisner C. Use of exclusion criteria in selecting research subjects and its effect on the generalisability of alcohol treatment outcome studies. Am J Psychiatry. 2000;157(4):588–94.

    Article  PubMed  CAS  Google Scholar 

  14. Pablos-Mendez A, Barr RG, Shea S. Run-in periods in randomized trials: implications for the application of results in clinical practice. J Am Med Assoc. 1998;279(3):222–5.

    Article  CAS  Google Scholar 

  15. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156(1):5–10.

    PubMed  CAS  Google Scholar 

  16. Swanson GM, Bailar JC. Selection and description of cancer clinical trials participants – science or happenstance? Cancer. 2002;95(5):950–9.

    Article  PubMed  Google Scholar 

  17. Kaiser Family Foundation (2005) Fact Sheet: African Americans and HIV/AIDS Update, Kaiser Family Foundation.

    Google Scholar 

  18. Tucker WH. The science and politics of racial research. Chicago, IL: University of Illinois Press; 1996.

    Google Scholar 

  19. Matthews HW. Racial, ethnic and gender differences in response to medicines. Drug Metabol Drug Interact. 1995;12(2):77–91.

    Article  PubMed  CAS  Google Scholar 

  20. Rosenthal MB, Frank RG, Li Z, Epstein AM. Early experience with pay-for-performance. J Am Med Assoc. 2005;294(14):1788–93.

    Article  CAS  Google Scholar 

  21. Werner RM, Asch DA, Polsky D. Racial profiling: the unintended consequences of coronary artery bypass graft report cards. Circulation. 2005;111(10):1257–63.

    Article  PubMed  Google Scholar 

  22. Eddy DM. Evidence-based medicine: a unified approach. Health Aff. 2005;24(1):9–17.

    Article  Google Scholar 

  23. Kerse N, Buetow S, Mainous AG, Young III G, Coster G, Arroll B. Physician-patient relationship and medication compliance: a primary care investigation. Ann Fam Med. 2004;2(5):455–61.

    Article  PubMed  Google Scholar 

  24. Bankole KK. Slavery and medicine: enslavement and medical practices in AnteBellum Louisiana. New York: Taylor & Francis; 1998.

    Google Scholar 

  25. Brandon DT, Isaac LA, LaVeist TA. The legacy of Tuskegee and trust in medical care: Is tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc. 2005;97(7):951–6.

    PubMed  Google Scholar 

  26. Fett SM. Working cures: healing, health, and power on southern slave plantations. 1st ed. Chapel Hill, NC: University of North Carolina Press; 2002.

    Google Scholar 

  27. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. In: Reverby SM, editor. Tuskegee’s truths: rethinking the Tuskegee Syphilis Study. Chapel Hill, NC: Univeristy of North Carolina Press; 2000. p. 656.

    Google Scholar 

  28. Airhihenbuwa CO. Health and culture: beyond the western paradigm. Thousand Oaks, CA: Sage Publications; 1995.

    Google Scholar 

  29. Sackett DL, Rosenberg WMC, Muir Gray JA, Haynes RB, Richardson WS. Evidence-based medicine: what it is and what it isn’t. BMJ. 1996;312:71–2.

    Article  PubMed  CAS  Google Scholar 

  30. Fox DM. Evidence of evidence-based health policy: the politics of systematic reviews in coverage decisions. Health Aff. 2005;24(1):114–22.

    Article  Google Scholar 

  31. Williams A. Priority setting in a needs-based system. In: Gelijns AC, editor. Medical innovations at the crossroads: technology and healthcare in an era of limits, vol. 3. Washington, DC: National Academies Press; 1992.

    Google Scholar 

  32. Mendelson D, Carino TV. Evidence-based medicine in the United States – DeRigueur or dream deferred? Health Aff. 2005;24(1):133–6.

    Article  Google Scholar 

  33. Committee on Quality of Health Care in America. Institute of Medicine. In: Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.

    Google Scholar 

  34. Claxton K, Cohen JT, Neumann PJ. When is evidence sufficient? A framework for making use of all available information in medical decision making and for deciding whether more is needed. Health Aff. 2005;24(1):93–101.

    Article  Google Scholar 

  35. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490–4.

    Article  Google Scholar 

  36. Rodwin MA. The politics of evidence-based medicine. J Health Polit Policy Law. 2001;26(2):439–46.

    Article  PubMed  CAS  Google Scholar 

  37. Gadson SL. One more river to cross – looking back, moving forward: advancing the NMA “Equality Agenda” in the era of 21st-century medicine. J Natl Med Assoc. 2005;97(10):1327–33.

    PubMed  Google Scholar 

  38. Rogers WA. Evidence based medicine and justice: a framework for looking at the impact of EBM upon vulnerable or disadvantaged groups. J Med Ethics. 2004;30(2):141–5.

    Article  PubMed  CAS  Google Scholar 

  39. US Department of Health and Human Services. 2004. Centers for medicare and medicaid services, 2003 CMS statistics, http://new.cms.hhs.gov/MedicareMedicaidStatSupp/downloads/03CMSstats.pdf.

  40. US Department of Health and Human Services. Healthy people 2010: understanding and improving health. 2nd ed. Washington, DC: US Department of Health and Human Services; 2000.

    Google Scholar 

  41. Allen CE. 2000 presidential address: eliminating health disparities. Am J Public Health. 2001;91(7):1142–3.

    Article  PubMed  CAS  Google Scholar 

  42. Teutsch SM, Berger ML, Weinstein MC. Comparative effectiveness: asking the right questions, choosing the right method. Health Aff. 2005;24(1):128–32.

    Article  Google Scholar 

  43. Semmes CE. Racism, health and post-industrialism: a theory of African American health. Westport, CT: Praeger Paperback; 1996.

    Google Scholar 

  44. Cohen HW, Northridge ME. Getting political: racism and urban health. Am J Public Health. 2000;90(6):841–2.

    Article  PubMed  CAS  Google Scholar 

  45. Kreiger N. Shades of difference: theoretical underpinnings of the medical controversy on Black-White differences in the United States, 1830–1870. Int J Health Serv. 1987;17(2):259–78.

    Article  Google Scholar 

  46. Martin DF, Maguire MG, Fine SL. Identifying and eliminating the roadblocks to comparative-effectiveness research. N Engl J Med. 2010;362(3):105–7.

    Article  Google Scholar 

  47. Poolsup N, Li Wan Po A, Knight TL. Pharmacogenetics and psychopharmacotherapy. J Clin Pharm Ther. 2000;25:197–220.

    Article  PubMed  CAS  Google Scholar 

  48. Taylor AL, Ziesche S, Yancy C, et al. African American heart failure trial. N Engl J Med. 2004;351:2049–57.

    Article  PubMed  CAS  Google Scholar 

  49. Yancy CW. Heart failure in African Americans: a cardiovascular enigma. J Card Fail. 2000;6:183–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Special thanks to the Alliance of Minority Medical Associations and the Commission on Health, Genetics, and Human Variation. The authors acknowledge the assistance of Health Policy Analyst and Science Writer, John Sankofa, who contributed significantly to the development of this chapter.

Author information

Authors and Affiliations

  1. Los Angeles, California, USA

    Randall W. Maxey

Authors
  1. Randall W. Maxey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Allen Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Randall W. Maxey .

Editor information

Editors and Affiliations

  1. Medicine at UCLA, and, The Minority Health Institute, Inc., The David Geffen School of, Clairton Place 3425, Los Angeles, 91436, California, USA

    Richard Allen Williams

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Maxey, R.W., Williams, R.A. (2011). Perspective: Second-Class Medicine – Implications of Evidence-Based Medicine for Improving Minority Access to Health Care. In: Williams, R. (eds) Healthcare Disparities at the Crossroads with Healthcare Reform. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7136-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-7136-4_8

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-7135-7

  • Online ISBN: 978-1-4419-7136-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation